Physician profile
Allison Nelson
NPI 1245709427
$4,078.36
in general payments reported to CMS, 2019-2025
34 companies · $991 in 2025
The $991 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $861 · 2022: $621 · 2023: $819 · 2024: $786 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,495 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,495.43 |
| Education | $100.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $733.98 | 2021-2025 | Wegovy, Saxenda |
| Abbvie INC. | $669.63 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $417.00 | 2021-2025 | Trintellix |
| Lilly USA, LLC | $320.99 | 2021-2025 | Zepbound, Jardiance, Mounjaro |
| Astellas Pharma US INC | $265.16 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $205.12 | 2021-2025 | Slynd |
| Axsome Therapeutics, INC. | $196.69 | 2022-2024 | Auvelity |
| Organon LLC | $139.67 | 2022-2025 | Nexplanon |
| Radius Health, INC. | $134.47 | 2021-2025 | Tymlos |
| Biohaven Pharmaceuticals, INC. | $118.74 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.98 | 2021-2025 | |
| Avion Pharmaceuticals | $68.90 | 2021-2022 | |
| Exact Sciences Corporation | $63.31 | 2024-2025 | Cologuard Collection Kit |
| Vivus LLC | $59.97 | 2023-2024 | Qsymia |
| Pfizer INC. | $57.25 | 2021-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $49.18 | 2023 | Myrisk |
| Idorsia Pharmaceuticals US INC | $44.60 | 2023-2024 | Quviviq |
| Lundbeck LLC | $44.43 | 2022-2023 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $43.25 | 2021-2023 | Ajovy |
| Amgen INC. | $42.72 | 2021 | |
| Biogen, INC. | $32.96 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $31.90 | 2024-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Merck Sharp & Dohme LLC | $30.45 | 2022-2023 | Gardasil 9 |
| Biohaven Pharmaceutical Holding Company LTD. | $24.02 | 2022 | |
| Mayne Pharma Commercial LLC | $21.48 | 2022 | |
| Seqirus USA INC | $21.17 | 2025 | Fluad, Flucelvax |
| Sumitomo Pharma America, INC. | $21.13 | 2025 | Myfembree |
| Urovant Sciences INC | $16.68 | 2022 | |
| Daiichi Sankyo INC. | $16.53 | 2021 | |
| Abbott Laboratories | $16.51 | 2025 | Alinity M |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.53 | 2021 | |
| Shield Therapeutics INC | $14.40 | 2023 | Accrufer |
| Neos Therapeutics, LP | $13.11 | 2023 | Adzenys Xr-Odt |
| Currax Pharmaceuticals LLC | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.